We’ve recently updated our valuation analysis.

Clicks Group Valuation

Is CLS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLS?

Other financial metrics that can be useful for relative valuation.

CLS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA17.5x
PEG Ratio3.6x

Price to Earnings Ratio vs Peers

How does CLS's PE Ratio compare to its peers?

The above table shows the PE ratio for CLS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average23.7x
DCP Dis-Chem Pharmacies
25.1x12.5%R26.1b
SHP Shoprite Holdings
23.3x11.2%R132.6b
BID Bid
25.5x14.6%R122.9b
PIK Pick n Pay Stores
21x21.7%R28.8b
CLS Clicks Group
24.5x6.9%R64.5b

Price-To-Earnings vs Peers: CLS is expensive based on its Price-To-Earnings Ratio (24.5x) compared to the peer average (23.7x).


Price to Earnings Ratio vs Industry

How does CLS's PE Ratio compare vs other companies in the Global Consumer Retailing Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a12.3%
n/an/an/a

Price-To-Earnings vs Industry: CLS is expensive based on its Price-To-Earnings Ratio (24.5x) compared to the Global Consumer Retailing industry average (16.7x)


Price to Earnings Ratio vs Fair Ratio

What is CLS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.5x
Fair PE Ratio18x

Price-To-Earnings vs Fair Ratio: CLS is expensive based on its Price-To-Earnings Ratio (24.5x) compared to the estimated Fair Price-To-Earnings Ratio (18x).


Share Price vs Fair Value

What is the Fair Price of CLS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLS (ZAR264.5) is trading above our estimate of fair value (ZAR141.33)

Significantly Below Fair Value: CLS is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentR264.50
R299.40
+13.2%
11.6%R330.00R236.00n/a5
Jan ’24R270.08
R302.80
+12.1%
12.5%R343.00R236.00n/a5
Dec ’23R282.46
R302.80
+7.2%
12.5%R343.00R236.00n/a5
Nov ’23R310.71
R319.50
+2.8%
6.2%R343.00R290.00n/a4
Oct ’23R285.46
R319.50
+11.9%
6.6%R338.00R284.00n/a4
Sep ’23R294.69
R312.00
+5.9%
5.8%R330.00R284.00n/a4
Aug ’23R283.59
R314.60
+10.9%
5.4%R330.00R284.00n/a5
Jul ’23R270.96
R314.60
+16.1%
5.4%R330.00R284.00n/a5
Jun ’23R303.95
R314.60
+3.5%
5.4%R330.00R284.00n/a5
May ’23R310.82
R317.00
+2.0%
7.1%R350.00R281.00n/a5
Apr ’23R307.24
R314.00
+2.2%
5.9%R335.00R281.00n/a5
Mar ’23R299.29
R312.00
+4.2%
6.3%R335.00R281.00n/a5
Feb ’23R293.48
R312.00
+6.3%
6.3%R335.00R281.00n/a5
Jan ’23R315.53
R306.00
-3.0%
5.5%R325.00R281.00R270.086
Dec ’22R289.10
R304.33
+5.3%
5.0%R321.00R281.00R282.466
Nov ’22R278.84
R301.00
+7.9%
4.9%R320.00R281.00R310.715
Oct ’22R272.00
R297.80
+9.5%
8.2%R331.00R258.00R285.465
Sep ’22R303.25
R279.00
-8.0%
10.4%R331.00R249.00R294.695
Aug ’22R265.08
R270.00
+1.9%
6.5%R301.00R249.00R283.595
Jul ’22R248.00
R268.83
+8.4%
6.1%R301.00R249.00R270.966
Jun ’22R255.86
R268.83
+5.1%
6.1%R301.00R249.00R303.956
May ’22R242.20
R261.67
+8.0%
2.5%R269.00R249.00R310.826
Apr ’22R236.02
R260.83
+10.5%
2.4%R268.00R249.00R307.246
Mar ’22R246.20
R262.67
+6.7%
3.8%R281.00R249.00R299.296
Feb ’22R248.50
R261.00
+5.0%
4.2%R281.00R249.00R293.486
Jan ’22R252.67
R258.33
+2.2%
3.7%R274.00R249.00R315.536

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies